In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View

Merck KGaA

https://www.merckgroup.com/en

Latest From Merck KGaA

Seagen, Astellas Data Support Broader Indication For Padcev/Keytruda Combo

Bookmark
  • Analysis
By Joseph Haas

With accelerated approval in advanced urothelial cancer, the sponsors now have data that could support full approval.

Clinical Trials Business Strategies

Deal Watch: Merck KGAA Teams With AI Biotechs On Drug Discovery Efforts

Bookmark
  • News
By Joseph Haas

Plus deals involving Debiopharm/SunRock, RefleXion/3B Pharmaceuticals, Pharmanovia/Sanofi and more.

Deal Watch Business Strategies

BenevolentAI Still Bullish As CEO Shields Steps Down

Bookmark
  • News
By Kevin Grogan

BenevolentAI has added Merck KGaA to its list of partners but the UK firm is looking for a new CEO after Joanna Shields decided to leave as a major restructuring continues.

Artificial Intelligence Business Strategies

Enzene CEO On Biosimilar Denosumab And Cetuximab; Medicare Negotiation Impact On US Market

Bookmark
  • Interviews
By Vibha Ravi

CEO of Enzene Biosciences weighs in on the impact of Medicare negotiations in the US on the biosimilars market even as a US filing is planned for a Prolia biosimilar. In the interview, he says Enzene “is not afraid or concerned” over ongoing litigation with Merck KGaA over an Erbitux biosimilar in India, adding that new modalities like ADCs are being “seriously” considered.

Business Strategies Commercial
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Pharmaceuticals
    • Drug Delivery
    • Nutraceuticals
  • Biotechnology
    • Synthesis Technologies, Production Processes
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Other Names / Subsidiaries
    • Acadiana Ventures Inc.
    • Allergopharma Joachim Ganzer KG
    • AmpTec GmbH
    • Asceneuron
    • Chord Therapeutics SA
    • EMD Pharmaceuticals
    • Grzybowski Scientific Inventions (GSI)
    • Intermolecular Inc
    • JRH Biosciences
    • Merck Hoei Ltd.
    • Millipore
    • MilliporeSigma
    • Ormet Circuts Inc.
    • Serono
    • EMD Serono, Inc.
    • Sigma-Aldrich
    • Versum Materials, Inc.
UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By